Target intelligence / Profile preview

Hemoglobin subunit beta Cysteine 93 (beta-Cys93) (beta-Cys93)

Target
beta-Cys93
Molecular classification
Hemoglobin subunit, Globular protein, Metalloprotein, Thiol-containing protein
01

Overview

Hemoglobin subunit beta Cysteine 93 (beta-Cys93) is a highly conserved and chemically reactive amino acid residue located on the surface of the hemoglobin molecule (UniProt P68871). It plays a critical role in the physiological regulation of blood pressure and oxygen delivery through its interaction with nitric oxide (NO), forming S-nitrosohemoglobin (SNO-Hb) (PubMed 12193634). This S-nitrosylation process is oxygen-dependent, allowing hemoglobin to act as a dynamic sensor and transporter of NO bioactivity throughout the vascular system (PubMed 21810405). In the context of disease, beta-Cys93 is a focal point for oxidative damage and has been investigated as a site for therapeutic intervention in conditions like sickle cell disease and hypoxia. By covalently modifying this residue, researchers aim to stabilize the high-affinity (R-state) conformation of hemoglobin, thereby preventing the polymerization of sickle hemoglobin or enhancing oxygen uptake in low-oxygen environments (PubMed 16107501). Furthermore, the reactivity of beta-Cys93 is a key consideration in the development of hemoglobin-based oxygen carriers (HBOCs) to mitigate the side effects of NO scavenging and vasoconstriction. Its unique position and reactivity make it a significant target for both physiological signaling and pharmacological modulation.

Other names
Cys93Beta-93 CysCysteine 93 of the beta-globin chainHBB Cys93Cys-beta93Hemoglobin beta-chain Cys93
02

Mechanism of action

Facilitation of S-nitrosylation to regulate vasodilation; covalent modification of the thiol group to stabilize the R-state (relaxed) conformation of hemoglobin, thereby increasing oxygen affinity and preventing hemoglobin polymerization.

03

Biological functions

Oxygen transportNitric oxide transportBlood pressure regulationRedox signalingVascular homeostasis
04

Disease associations

Sickle cell diseaseHypertensionHypoxiaIschemia-reperfusion injuryCarbon monoxide poisoning
05

Safety considerations

Risk of methemoglobinemiaImpaired oxygen release in peripheral tissues due to excessive oxygen affinity (left-shift)Potential for systemic hypertension if nitric oxide scavenging is increasedOxidative stress-induced hemolysis
06

Interacting drugs

Nitric oxide

4 more in the full profile.

07

Biomarkers

S-nitrosohemoglobin (SNO-Hb) levelsP50 (oxygen partial pressure at 50% saturation)Methemoglobin percentageErythrocyte oxidative stress markers

Beyond the preview

Go deeper on Hemoglobin subunit beta Cysteine 93 (beta-Cys93) (beta-Cys93).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit beta Cysteine 93 (beta-Cys93) (beta-Cys93).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call